European equities traded in the US as American depositary receipts were tracking slightly lower late Tuesday morning, declining 0.17% to 1,877.50 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by semiconductor company Sequans Communications (SQNS) and biopharmaceutical company DBV Technologies (DBVT), which climbed 19% and 13% respectively. They were followed by biopharmaceutical company Cellectis (CLLS) and internet browser company Opera (OPRA), which rose 7% and 6% respectively.
The decliners from continental Europe were led by accommodations booking company trivago (TRVG) and brewing company Anheuser-Busch InBev (BUD), which fell 3.9% and 2.8% respectively. They were followed by software firm SAP (SAP) and consumer goods company Unilever (UL), which lost 1.8% and 1.7% respectively.
The gainers from the UK were led by biopharmaceutical companies Akari Therapeutics (AKTX) and NuCana (NCNA), which advanced 7.6% and 3% respectively. They were followed by biopharmaceutical companies Bicycle Therapeutics (BCYC) and Mereo BioPharma Group (MREO), which increased 1.7% and 1.1% respectively.
The decliners from the UK and Ireland were led by biotech firm Trinity Biotech (TRIB) and alcoholic beverage company Diageo (DEO), which dropped 3.6% and 3.2% respectively. They were followed by biopharmaceutical company Amarin (AMRN) and mining company BHP Group (BHP), which lost 1.7% and 1.6% respectively.
Comments